| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |